EVUAX | VUIAX | EVUAX / VUIAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 31 years | 21 years | - |
Gain YTD | 15.719 | 21.108 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 331M | 8.78B | 4% |
Annual Yield % from dividends | 2.19 | 3.32 | 66% |
Returns for 1 year | 16.29 | 21.76 | 75% |
Returns for 3 years | -6.29 | 8.49 | -74% |
Returns for 5 years | -13.78 | 16.71 | -82% |
Returns for 10 years | 5.06 | 55.92 | 9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIVPX | 10.19 | 0.03 | +0.30% |
Fidelity Advisor International Value M | |||
SBHIX | 22.93 | 0.04 | +0.17% |
Saratoga Health & Biotechnology I | |||
IGRFX | 30.54 | 0.01 | +0.03% |
Delaware Ivy Mid Cap Growth R6 | |||
IVGIX | 22.40 | N/A | N/A |
VY® Invesco Growth and Income I | |||
HLEZX | 16.95 | N/A | N/A |
Harding Loevner Instl Emerg Mkts Z |